Morning Breakouts

Latest California Healthline Stories

Seven Hospitals Agree To Pay More Than $6.3M for ‘Illegally’ Billing Government for Some Procedures

The Department of Justice announced yesterday that seven hospitals have agreed to pay more than $6.3 million to settle allegations that they illegally billed the federal government for procedures that were not reimbursable, Reuters News reports.

Attorneys General from 29 States Sue Bristol-Myers Squibb Over Delays on Generic Competition

Attorneys general from 29 states yesterday filed suit against Bristol-Myers Squibb Co., alleging that the pharmaceutical company made “knowing, willful and fraudulent material misrepresentation” on patent applications for the cancer treatment Taxol to delay generic competition, the Wall Street Journal reports.

University of Nevada Medical School Will Not Participate in Revised Medical Malpractice Insurance Plan

University of Nevada School of Medicine officials said that they will not participate in the revised Medical Liability Association of Nevada — a state program established to help doctors meet their medical malpractice insurance costs — and plan to select one of three private insurers to cover medical residents and the 250 full-time and 150 part-time physicians employed at the medical school, the Las Vegas Sun reports.

Editorials Look at FDA Fast-Track Approval for Treatments for Bioterrorism Related-Diseases

The FDA’s decision to allow approval of certain drugs that would protect people from biological, chemical or nuclear attacks without requiring clinical trials in humans “makes sense,” even if the process is not “foolproof,” the New York Times writes in an editorial.

Davis’ Proposed Budget Would Cut $12M from Public Insurance Outreach Programs

Gov. Gray Davis’ (D) proposed fiscal year 2002-2003 budget would cut $12 million in funds used to advertise Medi-Cal and Healthy Families, including $6 million for school- and community-based outreach programs that employ workers to enroll eligible individuals, the Los Angeles Times reports.

Prescription Pain Relievers Overprescribed, Overpriced, Express Scripts Survey Finds

Pain relievers known as Cox-2 inhibitors, such as Vioxx and Celebrex, are “over-prescribed, overpriced, and an unnecessary expense for health plans,” according to a study released yesterday by the pharmacy benefits manager Express Scripts Inc., the Washington Post reports.